Cargando…

Effect of delayed palliative chemotherapy on survival of patients with recurrent ovarian cancer

For patients with recurrent ovarian cancer, the goals of chemotherapy include palliation of disease-related symptoms with minimum treatment-related side effects. However, there is currently a paucity of data regarding the initiation of palliative chemotherapy. This study aimed to compare the differe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pyeon, Seung Yeon, Han, Gwan Hee, Ki, Kyung Do, Lee, Kwang-Beom, Lee, Jong-Min
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7377458/ https://www.ncbi.nlm.nih.gov/pubmed/32701994 http://dx.doi.org/10.1371/journal.pone.0236244

Ejemplares similares

Abnormally high level of CA-19-9 in a benign ovarian cyst
por: Pyeon, Seung-Yeon, et al.
Publicado: (2015)

Syndrome of inappropriate antidiuretic hormone secretion following irinotecan-cisplatin administration as a treatment for recurrent ovarian clear cell carcinoma
por: Kwon, Do Youn, et al.
Publicado: (2017)

A case of successful salvage chemotherapy of recurrent ovarian sertoli-leydig cell tumor
por: Lim, Soyi, et al.
Publicado: (2013)

Efficacy of cisplatin combined with topotecan in patients with advanced or recurrent ovarian cancer as second- or higher-line palliative chemotherapy
por: Lee, Myung-Won, et al.
Publicado: (2020)

Immunological modifications following chemotherapy are associated with delayed recurrence of ovarian cancer
por: Adzibolosu, Nicholas, et al.
Publicado: (2023)

Efficacy of cisplatin combined with vinorelbine as second- or higher-line palliative chemotherapy in patients with advanced ovarian cancer
por: Yeon, Sang Hoon, et al.
Publicado: (2023)

Skeletal muscle depletion predicts survival of patients with advanced biliary tract cancer undergoing palliative chemotherapy
por: Cho, Kyoung-Min, et al.
Publicado: (2017)

Rethinking the next step after unexpected results associated with minimally invasive radical hysterectomy for early cervical cancer
por: Pyeon, Seung Yeon, et al.
Publicado: (2019)

Comparison between adjuvant chemotherapy and adjuvant radiotherapy/chemoradiotherapy after radical surgery in patients with cervical cancer: a meta-analysis
por: Lee, Kwang-Beom, et al.
Publicado: (2018)

Retrospective Analysis of Survival Improvement by Molecular Biomarker-Based Personalized Chemotherapy for Recurrent Ovarian Cancer
por: Kim, Youngchul, et al.
Publicado: (2014)

Survival outcomes and toxicity of intraoperative intraperitoneal chemotherapy in advanced epithelial ovarian cancer
por: Yoon, Ji-Young, et al.
Publicado: (2014)

Clinical Course and Predictors of Subsequent Recurrence and Survival of Patients With Ipsilateral Breast Tumor Recurrence
por: Baek, Soo Yeon, et al.
Publicado: (2022)

Right ventricular metastatic tumor from a primary carcinoma of uterine cervix: A cause of pulmonary embolism
por: Han, Gwan Hee, et al.
Publicado: (2017)

Sarcoidosis Mimicking Cancer Metastasis Following Chemotherapy for Ovarian Cancer
por: Kim, Mi Hyun, et al.
Publicado: (2013)

Interval between secondary cytoreductive surgery and adjuvant chemotherapy is not associated with survivals in patients with recurrent ovarian cancer
por: Jeong, Soo Young, et al.
Publicado: (2019)

Conditional survival estimate in patients with Barcelona Clinic Liver Cancer stage B/C hepatocellular carcinoma treated with hepatic arterial infusion chemotherapy with/without concurrent radiotherapy
por: Cho, In Rae, et al.
Publicado: (2017)

Identification of Patients with Recurrent Epithelial Ovarian Cancer Who Will Benefit from More Than Three Lines of Chemotherapy
por: Seol, Aeran, et al.
Publicado: (2022)

Survival impact of extended cycles of second-line chemotherapy in platinum-sensitive relapsed ovarian cancer patients with residual tumor after six cycles
por: Kim, Se Ik, et al.
Publicado: (2020)

Long-term Survival after Repeated Local Therapy and Salvage Chemotherapy for Recurrent Metastases from Gastric Cancer: a Case Report and Literature Review
por: Kwon, Jihyun, et al.
Publicado: (2018)

Feasibility of Oxaliplatin, Leucovorin, and 5-Fluorouracil (FOLFOX-4) Chemotherapy in Heavily Pretreated Patients with Recurrent Epithelial Ovarian Cancer
por: Lee, Hee Jun, et al.
Publicado: (2013)

Evaluating the recent developments in palliative chemotherapy for metastatic colorectal cancer
por: Baek, Sun Kyung, et al.
Publicado: (2019)

Oncologic outcomes of adjuvant chemotherapy alone after radical surgery for stage IB–IIA cervical cancer patients
por: Lee, Kwang-Beom, et al.
Publicado: (2018)

Comparison of Surgery Plus Chemotherapy and Palliative Chemotherapy Alone for Advanced Gastric Cancer with Krukenberg Tumor
por: Cho, Jang Ho, et al.
Publicado: (2015)

Recurrent cervical cancer treated with palliative chemotherapy: real-world outcome
por: Mailankody, Sharada, et al.
Publicado: (2020)

The Effect of Body Mass Index on Survival in Advanced Epithelial Ovarian Cancer
por: Bae, Hyo Sook, et al.
Publicado: (2014)

ERRATUM: Comparison of Surgery Plus Chemotherapy and Palliative Chemotherapy Alone for Advanced Gastric Cancer with Krukenberg Tumor
por: Cho, Jang Ho, et al.
Publicado: (2018)

Hyperthermic intraperitoneal chemotherapy for recurrent epithelial ovarian cancer
por: Chen, Wei-Chun, et al.
Publicado: (2022)

Survival outcomes of breast cancer patients with recurrence after surgery according to period and subtype
por: Lee, Young-jin, et al.
Publicado: (2023)

Weekly platinum chemotherapy for recurrent ovarian cancer
por: Clamp, A, et al.
Publicado: (2002)

The feasibility and efficacy of gonadotropin-releasing hormone agonists for prevention of chemotherapy induced ovarian failure in patient with gynecological malignancies
por: Park, Chan-Yong, et al.
Publicado: (2014)

Postoperative Hormone Replacement Therapy and Survival in Women with Ovarian Cancer
por: Ji, Eunjeong, et al.
Publicado: (2022)

Sugammadex is associated with shorter hospital length of stay after open lobectomy for lung cancer: a retrospective observational study
por: Song, Seung Won, et al.
Publicado: (2021)

The Addition of Transarterial Chemoembolization to Palliative Chemotherapy Extends Survival in Intrahepatic Cholangiocarcinoma
por: Gairing, Simon Johannes, et al.
Publicado: (2021)

The survival impact of palliative chemotherapy dose modifications on metastatic colon cancer
por: Zainal Abidin, Mohd Naqib, et al.
Publicado: (2022)

The Impact of Palliative Chemotherapy on the Survival of Patients With Metastatic Colorectal Cancer in Jordan
por: Alkader, Mohammad S, et al.
Publicado: (2023)

Elevated CEA is associated with worse survival in recurrent rectal cancer
por: Cho, Won Kyung, et al.
Publicado: (2017)

Excellent Response to Palliative Chemotherapy for Pleural Recurrence of Uterine Papillary Serous Carcinoma
por: Singh, Shantanu, et al.
Publicado: (2013)

The retrospective cohort study for survival rate in patients with advanced hepatocellular carcinoma receiving radiotherapy or palliative care
por: Eun, Hyuk Soo, et al.
Publicado: (2011)

Palliative systemic therapy for women with recurrent epithelial ovarian cancer: current options
por: Elit, Laurie, et al.
Publicado: (2013)

Impact of Hyperglycemia on Survival and Infection-Related Adverse Events in Patients with Metastatic Colorectal Cancer Who Were Receiving Palliative Chemotherapy
por: Hong, Yong Joo, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_vt1tdq8g1mp2siabsg96u07etb